Cash flow Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-20 pm EST			5-day change	1st Jan Change
77.73 ^USD	-2.81%		+2.52%	+2.84%

12:13pm	Mizuho Adjusts Price Target on Henry Schein to $81 From $74, Maintains Neutral Rating	MT
Jan. 18	Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%	MT

b38a.o1Z_k6y7B68WexaUC2IU5cj0ZmeKNoJeWkLL1AL7K4k.5TARxM3vZPdANiTBURdsvfmSVDPcYtYvHR2tv3evbNuVEBL82_VR7W8fVw

Published financial data: HENRY SCHEIN, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	10.12B	12.4B	12.65B	12.34B	12.67B
Total Revenues	10.12B	12.4B	12.65B	12.34B	12.67B
Cost of Goods Sold, Total	7.3B	8.73B	8.82B	8.48B	8.66B
Gross Profit	2.81B	3.67B	3.83B	3.86B	4.02B
Selling General & Admin Expenses, Total	2.25B	2.82B	2.77B	2.96B	3.02B
Depreciation & Amortization - (IS)	-	-	182M	210M	251M
Other Operating Expenses, Total	2.25B	2.82B	2.95B	3.17B	3.27B
Operating Income	566M	848M	878M	695M	746M
Interest Expense, Total	-41.38M	-27.6M	-44M	-87M	-131M
Interest And Investment Income	9.84M	6.45M	17M	17M	24M
Net Interest Expenses	-31.54M	-21.15M	-27M	-70M	-107M
Income (Loss) On Equity Invest.	12.34M	20.01M	15M	14M	13M
Other Non Operating Income (Expenses)	17.33M	12.14M	1M	-3M	-1M
EBT, Excl. Unusual Items	565M	859M	867M	636M	651M
Restructuring Charges	-32.09M	-7.94M	-131M	-80M	-110M
Merger & Related Restructuring Charges	-	-	-	-	-6M
Gain (Loss) On Sale Of Investments	1.57M	7.32M	-	-	-
Asset Writedown	-20.28M	-713K	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-9M
EBT, Incl. Unusual Items	514M	858M	736M	556M	526M
Income Tax Expense	95.37M	197M	170M	120M	128M
Earnings From Continuing Operations	418M	661M	566M	436M	398M
Earnings Of Discontinued Operations	986K	-	-	-	-
Net Income to Company	419M	661M	566M	436M	398M
Minority Interest	-15.63M	-29.29M	-28M	-20M	-8M
Net Income - (IS)	404M	631M	538M	416M	390M
Net Income to Common Incl Extra Items	404M	631M	538M	416M	390M
Net Income to Common Excl. Extra Items	403M	631M	538M	416M	390M
Per Share Items
Net EPS - Basic	2.83	4.51	3.95	3.18	3.08
Basic EPS - Continuing Operations	2.83	4.51	3.95	3.18	3.08
Basic Weighted Average Shares Outstanding	143M	140M	136M	131M	127M
Net EPS - Diluted	2.82	4.45	3.91	3.16	3.05
Diluted EPS - Continuing Operations	2.81	4.45	3.91	3.16	3.05
Diluted Weighted Average Shares Outstanding	143M	142M	138M	132M	128M
Normalized Basic EPS	2.37	3.62	3.78	2.89	3.15
Normalized Diluted EPS	2.35	3.58	3.73	2.87	3.12
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	752M	1.06B	1.09B	943M	1.01B
EBITA	672M	972M	1B	847M	931M
EBIT	566M	848M	878M	695M	746M
EBITDAR	838M	1.16B	1.24B	1.06B	1.14B
Effective Tax Rate - (Ratio)	18.56	23	23.1	21.58	24.33
Current Domestic Taxes	108M	166M	199M	100M	133M
Current Foreign Taxes	40.8M	42.75M	44M	40M	56M
Total Current Taxes	148M	208M	243M	140M	189M
Deferred Domestic Taxes	-22.92M	-14.68M	-61M	6M	-41M
Deferred Foreign Taxes	-30.06M	3.7M	-12M	-26M	-20M
Total Deferred Taxes	-52.98M	-10.98M	-73M	-20M	-61M
Normalized Net Income	337M	508M	514M	378M	399M
Interest on Long-Term Debt	115K	114K	-	-	-
Non-Cash Pension Expense	-	708K	1M	-1M	-1M
Supplemental Operating Expense Items
Advertising Expense	30.8M	45.9M	47M	47M	43M
Selling and Marketing Expenses	79.2M	96.7M	-	-	-
Net Rental Expense, Total	86.2M	103M	150M	121M	130M
Imputed Operating Lease Interest Expense	28.52M	20.59M	38.91M	39.74M	48.45M
Imputed Operating Lease Depreciation	57.68M	82.87M	111M	81.26M	81.55M
Stock-Based Comp., SG&A Exp. (Total)	8.79M	78.42M	54M	39M	39M
Total Stock-Based Compensation	8.79M	78.42M	54M	39M	39M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	421M	118M	117M	171M	122M
Total Cash And Short Term Investments	421M	118M	117M	171M	122M
Accounts Receivable, Total	1.42B	1.45B	1.44B	1.86B	1.48B
Total Receivables	1.42B	1.45B	1.44B	1.86B	1.48B
Inventory	1.51B	1.86B	1.96B	1.82B	1.81B
Prepaid Expenses	433M	413M	466M	639M	569M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	3.79B	3.84B	3.99B	4.49B	3.98B
Gross Property Plant And Equipment	1.16B	1.24B	1.24B	1.5B	1.49B
Accumulated Depreciation	-526M	-550M	-573M	-672M	-670M
Net Property Plant And Equipment	631M	691M	667M	823M	824M
Long-term Investments	169M	168M	161M	180M	170M
Goodwill	2.5B	2.85B	2.89B	3.88B	3.89B
Other Intangibles, Total	527M	733M	666M	1.01B	1.11B
Loans Receivable Long-Term	34.76M	35.75M	28M	44M	63M
Deferred Tax Assets Long-Term	42.59M	34.61M	88M	38M	47M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	72.06M	120M	116M	114M	131M
Total Assets	7.77B	8.48B	8.61B	10.57B	10.22B
Liabilities
Accounts Payable, Total	1.01B	1.05B	1B	1.02B	962M
Accrued Expenses, Total	819M	885M	796M	920M	794M
Short-term Borrowings	73.37M	50.53M	103M	264M	650M
Current Portion of Long-Term Debt	107M	7.42M	2M	146M	56M
Current Portion of Leases	67.14M	79.61M	77M	84M	78M
Current Income Taxes Payable	139M	137M	132M	137M	139M
Unearned Revenue Current, Total	71.5M	89.2M	86M	89M	81M
Other Current Liabilities	-	4.32M	24M	23M	43M
Total Current Liabilities	2.28B	2.31B	2.22B	2.68B	2.8B
Long-Term Debt	512M	807M	1.03B	1.93B	1.83B
Long-Term Leases	242M	272M	281M	314M	262M
Unearned Revenue Non Current	8.2M	9.7M	8M	9M	8M
Pension & Other Post Retirement Benefits	-	52.15M	59M	65M	68M
Deferred Tax Liability Non Current	30.06M	42.28M	36M	54M	102M
Other Non Current Liabilities	385M	315M	294M	362M	311M
Total Liabilities	3.46B	3.8B	3.94B	5.42B	5.38B
Common Stock, Total	1.42M	1.37M	1M	1M	1M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	3.45B	3.6B	3.68B	3.86B	3.77B
Comprehensive Income and Other	-108M	-171M	-233M	-206M	-379M
Total Common Equity	3.35B	3.43B	3.45B	3.66B	3.39B
Minority Interest	964M	1.25B	1.22B	1.5B	1.44B
Total Equity	4.31B	4.68B	4.67B	5.15B	4.84B
Total Liabilities And Equity	7.77B	8.48B	8.61B	10.57B	10.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	142M	137M	131M	129M	124M
ECS Total Common Shares Outstanding	142M	137M	132M	129M	124M
Book Value / Share	23.5	24.97	26.15	28.28	27.33
Tangible Book Value	317M	-162M	-113M	-1.23B	-1.61B
Tangible Book Value Per Share	2.22	-1.18	-0.86	-9.52	-12.94
Total Debt	1B	1.22B	1.5B	2.74B	2.87B
Net Debt	581M	1.1B	1.38B	2.57B	2.75B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	53.14M	35M	39M	39M
Debt Equivalent Oper. Leases	690M	828M	1.2B	968M	1.04B
Minority Interest, Total (Incl. Fin. Div)	964M	1.25B	1.22B	1.5B	1.44B
Equity Method Investments, Total	169M	168M	161M	180M	170M
Account Code - Inventory Valuation	5	5	5	5	6
Inventories - Raw Materials, Total	-	-	-	-	61M
Inventories - Work In Process, Total	-	-	-	-	39M
Inventories - Finished Goods, Total	-	-	-	-	1.71B
Land - (BS)	20.3M	21.12M	20M	21M	20M
Buildings, Total	145M	140M	135M	166M	164M
Machinery, Total	595M	658M	707M	880M	908M
Full Time Employees	19K	21.6K	22K	25K	25K
Accumulated Allowance for Doubtful Accounts (Supple)	88.03M	67.17M	65M	83M	78M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	404M	631M	538M	416M	390M
Depreciation & Amortization - CF	79.64M	85.73M	86M	96M	83M
Amortization of Goodwill and Intangible Assets - (CF)	106M	124M	126M	152M	185M
Depreciation & Amortization, Total	186M	210M	212M	248M	268M
(Gain) Loss From Sale Of Asset	-	-	-	-	29M
(Gain) Loss on Sale of Investments - (CF)	-2.1M	-9.76M	-	-	-
Asset Writedown & Restructuring Costs	20.28M	713K	127M	61M	44M
(Income) Loss On Equity Investments - (CF)	3.66M	-2.25M	0	1M	-1M
Stock-Based Compensation (CF)	8.79M	78.42M	54M	39M	39M
Provision and Write-off of Bad Debts	35.14M	-7.75M	5M	18M	14M
Net Cash From Discontinued Operations	5.39M	-	-	-	-
Other Operating Activities, Total	-58.2M	6.64M	-53M	7M	-75M
Change In Accounts Receivable	-189M	4.16M	-7M	-327M	315M
Change In Inventories	-31.82M	-295M	-126M	231M	-59M
Change In Accounts Payable	224M	84.71M	-96M	-56M	-163M
Change in Other Net Operating Assets	-6.48M	9.06M	-52M	-138M	47M
Cash from Operations	599M	710M	602M	500M	848M
Capital Expenditure	-48.83M	-79.02M	-96M	-147M	-148M
Cash Acquisitions	-	-579M	-158M	-1.02B	-
Sale (Purchase) of Intangible assets	-	-	-	-40M	-39M
Investment in Marketable and Equity Securities, Total	-46.15M	18.02M	-	65M	-230M
Other Investing Activities, Total	-20.04M	-37.4M	-22M	7M	-13M
Cash from Investing	-115M	-677M	-276M	-1.14B	-430M
Short Term Debt Issued, Total	45.08M	-	48M	153M	387M
Long-Term Debt Issued, Total	501M	305M	270M	1.37B	120M
Total Debt Issued	547M	305M	318M	1.52B	507M
Short Term Debt Repaid, Total	-	-18.41M	-	-	-
Long-Term Debt Repaid, Total	-611M	-122M	-59M	-468M	-318M
Total Debt Repaid	-611M	-141M	-59M	-468M	-318M
Issuance of Common Stock	-	-	2M	1M	6M
Repurchase of Common Stock	-88.09M	-409M	-517M	-284M	-394M
Other Financing Activities, Total	-34.38M	-88.6M	-59M	-69M	-311M
Cash from Financing	-187M	-333M	-315M	701M	-510M
Foreign Exchange Rate Adjustments	18.38M	-2.63M	-12M	-12M	43M
Net Change in Cash	315M	-303M	-1M	54M	-49M
Supplemental Items
Cash Interest Paid	43.12M	29.46M	47M	84M	132M
Cash Income Tax Paid (Refund)	207M	242M	265M	218M	144M
Levered Free Cash Flow	420M	500M	419M	181M	800M
Unlevered Free Cash Flow	446M	517M	447M	235M	882M
Change In Net Working Capital	53.84M	222M	272M	299M	-296M
Net Debt Issued / Repaid	-64.71M	164M	259M	1.05B	189M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.74	6.52	6.42	4.53	4.49
Return on Total Capital	6.92	9.46	9.1	6.18	5.97
Return On Equity %	10.17	14.7	12.11	8.88	7.97
Return on Common Equity	12.69	18.64	15.66	11.72	11.07
Margin Analysis
Gross Profit Margin %	27.81	29.61	30.29	31.29	31.69
SG&A Margin	22.21	22.77	21.91	23.96	23.82
EBITDA Margin %	7.43	8.53	8.62	7.64	8
EBITA Margin %	6.64	7.84	7.94	6.86	7.35
EBIT Margin %	5.6	6.84	6.94	5.63	5.89
Income From Continuing Operations Margin %	4.14	5.33	4.48	3.53	3.14
Net Income Margin %	3.99	5.09	4.25	3.37	3.08
Net Avail. For Common Margin %	3.98	5.09	4.25	3.37	3.08
Normalized Net Income Margin	3.33	4.09	4.06	3.06	3.15
Levered Free Cash Flow Margin	4.15	4.03	3.32	1.47	6.32
Unlevered Free Cash Flow Margin	4.4	4.17	3.53	1.91	6.96
Asset Turnover
Asset Turnover	1.36	1.53	1.48	1.29	1.22
Fixed Assets Turnover	16.98	18.76	18.63	16.56	15.39
Receivables Turnover (Average Receivables)	7.58	8.62	8.74	7.47	7.58
Inventory Turnover (Average Inventory)	4.97	5.17	4.61	4.49	4.78
Short Term Liquidity
Current Ratio	1.66	1.67	1.79	1.67	1.42
Quick Ratio	0.81	0.68	0.7	0.76	0.57
Operating Cash Flow to Current Liabilities	0.26	0.31	0.27	0.19	0.3
Days Sales Outstanding (Average Receivables)	48.04	42.22	42.45	48.75	48.04
Days Outstanding Inventory (Average Inventory)	73.28	70.34	80.46	81.1	76.21
Average Days Payable Outstanding	46.46	41.29	42.81	44.22	41.69
Cash Conversion Cycle (Average Days)	74.87	71.27	80.1	85.63	82.56
Long Term Solvency
Total Debt/Equity	23.25	26.02	32.05	53.19	59.4
Total Debt / Total Capital	18.86	20.65	24.27	34.72	37.26
LT Debt/Equity	17.5	23.08	28.15	43.61	43.19
Long-Term Debt / Total Capital	14.2	18.31	21.32	28.46	27.09
Total Liabilities / Total Assets	44.52	44.86	45.73	51.26	52.66
EBIT / Interest Expense	13.69	30.73	19.95	7.99	5.69
EBITDA / Interest Expense	20.26	42.07	28.18	12.23	8.73
(EBITDA - Capex) / Interest Expense	19.08	39.21	26	10.54	7.6
Total Debt / EBITDA	1.2	1.05	1.21	2.58	2.51
Net Debt / EBITDA	0.69	0.95	1.11	2.42	2.4
Total Debt / (EBITDA - Capex)	1.27	1.12	1.31	2.99	2.88
Net Debt / (EBITDA - Capex)	0.74	1.02	1.21	2.8	2.76
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.34	22.55	1.98	-2.44	2.71
Gross Profit, 1 Yr. Growth %	-8.95	30.49	4.27	0.78	4.04
EBITDA, 1 Yr. Growth %	-18.07	40.65	1.87	-13.49	6.74
EBITA, 1 Yr. Growth %	-20.08	44.56	2.03	-15.64	5.8
EBIT, 1 Yr. Growth %	-22.72	49.74	2.09	-20.84	2.47
Earnings From Cont. Operations, 1 Yr. Growth %	-42.32	57.86	-14.24	-22.97	-8.72
Net Income, 1 Yr. Growth %	-41.88	56.33	-14.74	-22.68	-6.25
Normalized Net Income, 1 Yr. Growth %	-19.86	50.54	1.18	-26.54	0.19
Diluted EPS Before Extra, 1 Yr. Growth %	-40.09	58.36	-12.13	-19.18	-3.48
Accounts Receivable, 1 Yr. Growth %	14.33	1.9	-0.69	29.2	-20.45
Inventory, 1 Yr. Growth %	5.86	23.05	5.48	-7.54	-0.28
Net Property, Plant and Equip., 1 Yr. Growth %	12.39	9.6	-3.47	23.39	0.12
Total Assets, 1 Yr. Growth %	8.69	9.12	1.49	22.84	-3.36
Tangible Book Value, 1 Yr. Growth %	-497	-151.15	-30.25	989.38	30.54
Common Equity, 1 Yr. Growth %	11.68	2.3	0.61	6.06	-7.17
Cash From Operations, 1 Yr. Growth %	-8.44	18.48	-15.21	-16.94	69.6
Capital Expenditures, 1 Yr. Growth %	-35.94	61.82	21.52	53.12	0.68
Levered Free Cash Flow, 1 Yr. Growth %	-63.75	19.03	-17.32	-53.93	383.25
Unlevered Free Cash Flow, 1 Yr. Growth %	-62.54	15.99	-14.83	-43.25	301.02
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.66	11.44	11.8	-0.25	0.1
Gross Profit, 2 Yr. CAGR %	-1.67	9	16.64	2.51	2.39
EBITDA, 2 Yr. CAGR %	-5.22	7.35	20.31	-6.12	-3.15
EBITA, 2 Yr. CAGR %	-6.48	7.49	22.14	-7.22	-4.13
EBIT, 2 Yr. CAGR %	-9.62	7.57	24.44	-10.1	-8.29
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.62	-4.58	16.23	-18.72	-16.14
Net Income, 2 Yr. CAGR %	-13.19	-4.68	15.4	-18.8	-14.86
Normalized Net Income, 2 Yr. CAGR %	-6.65	9.84	25.94	-13.79	-12.38
Diluted EPS Before Extra, 2 Yr. CAGR %	0.18	-2.59	17.96	-15.73	-11.68
Accounts Receivable, 2 Yr. CAGR %	10.41	7.93	0.6	13.27	1.38
Inventory, 2 Yr. CAGR %	3.37	14.13	13.92	-1.24	-3.98
Net Property, Plant and Equip., 2 Yr. CAGR %	41.69	10.99	2.83	9.13	11.15
Total Assets, 2 Yr. CAGR %	-4.38	8.9	5.23	11.65	8.96
Tangible Book Value, 2 Yr. CAGR %	-17.56	42.5	-40.27	175.66	277.11
Common Equity, 2 Yr. CAGR %	6.33	6.89	1.45	3.3	-0.77
Cash From Operations, 2 Yr. CAGR %	-6.47	4.16	0.25	-16.08	18.69
Capital Expenditures, 2 Yr. CAGR %	-17.24	1.82	39.97	36.41	24.16
Levered Free Cash Flow, 2 Yr. CAGR %	-5.72	-34.31	-0.2	-38.25	45.03
Unlevered Free Cash Flow, 2 Yr. CAGR %	-7.4	-34.08	0.02	-30.8	48.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.44	9.61	8.19	6.84	0.73
Gross Profit, 3 Yr. CAGR %	0.81	8.05	7.42	11.09	3.01
EBITDA, 3 Yr. CAGR %	-2.4	8.11	5.9	7.79	-1.78
EBITA, 3 Yr. CAGR %	-3.38	8.13	6.07	7.97	-1.83
EBIT, 3 Yr. CAGR %	-5.68	6.94	6.2	7.02	-4.63
Earnings From Cont. Operations, 3 Yr. CAGR %	9.53	13.61	-7.94	1.33	-15.52
Net Income, 3 Yr. CAGR %	-0.21	5.61	-8.17	0.98	-14.82
Normalized Net Income, 3 Yr. CAGR %	-4	9.47	6.89	5.23	-7.74
Diluted EPS Before Extra, 3 Yr. CAGR %	14.95	16.7	-5.88	3.99	-11.83
Accounts Receivable, 3 Yr. CAGR %	-2.19	7.5	4.98	9.35	0.68
Inventory, 3 Yr. CAGR %	-7.86	9.55	11.17	6.27	-0.92
Net Property, Plant and Equip., 3 Yr. CAGR %	18.93	30.07	5.92	9.27	6.04
Total Assets, 3 Yr. CAGR %	-0.39	-0.08	6.37	10.8	6.41
Tangible Book Value, 3 Yr. CAGR %	17.3	-29.69	12.31	57.23	114.87
Common Equity, 3 Yr. CAGR %	6	4.97	4.75	2.97	-0.31
Cash From Operations, 3 Yr. CAGR %	3.16	1.2	-2.73	-5.84	6.1
Capital Expenditures, 3 Yr. CAGR %	-7.85	3.49	7.99	44.22	23.28
Levered Free Cash Flow, 3 Yr. CAGR %	51.49	1.9	-28.73	-24.52	19.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	42.92	-0.18	-27.86	-19.22	21.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.98	1.39	7.32	5.55	4.88
Gross Profit, 5 Yr. CAGR %	-1.32	2.62	6.88	5.81	5.38
EBITDA, 5 Yr. CAGR %	-4.12	1.39	6.15	2.41	2.01
EBITA, 5 Yr. CAGR %	-4.84	1.2	6.14	1.96	2.05
EBIT, 5 Yr. CAGR %	-5.93	0.74	5.4	0.04	0.35
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.38	3.49	12.19	-0.65	-11.31
Net Income, 5 Yr. CAGR %	-3.36	4.49	5.78	-4.94	-10.91
Normalized Net Income, 5 Yr. CAGR %	-5.04	1.86	6.15	-0.49	-1.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.28	7.5	16.15	2.45	-8.25
Accounts Receivable, 5 Yr. CAGR %	2.99	2.97	-1.08	9.77	3.53
Inventory, 5 Yr. CAGR %	0.03	2.24	0.3	5.1	4.84
Net Property, Plant and Equip., 5 Yr. CAGR %	14.65	15.67	12.21	21.24	7.98
Total Assets, 5 Yr. CAGR %	3.63	4.64	1.82	4.46	7.4
Tangible Book Value, 5 Yr. CAGR %	-2.16	6.56	-10.45	21.44	82.32
Common Equity, 5 Yr. CAGR %	3.03	4.16	4.15	4.3	2.51
Cash From Operations, 5 Yr. CAGR %	-0.54	2	1.99	-6.09	5.33
Capital Expenditures, 5 Yr. CAGR %	-7.39	2.4	9	15.58	14.19
Levered Free Cash Flow, 5 Yr. CAGR %	-2.26	-1.67	28.27	-17.46	-7.12
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.75	-1.71	23.95	-14.66	-5.81